The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
Open accessAbstract
BACKGROUND: Synaptic degeneration is a central pathogenic event in Alzheimer's disease that occurs early during the course of disease and correlates with cognitive symptoms. The pre-synaptic vesicle protein synaptotagmin-1 appears to be essential for the maintenance of an intact synaptic transmission and cognitive function. Synaptotagmin-1 in cerebrospinal fluid is a candidate Alzheimer biomarker for synaptic dysfunction that also may correlate with cognitive decline. METHODS: In this study, a novel mass spectrometry-based assay for measurement of cerebrospinal fluid synaptotagmin-1 was developed, and was evaluated in two independent sample sets of patients and controls. Sample set I included cerebrospinal fluid samples from patients with dementia due to Alzheimer's disease (N = 17, age 52-86 years), patients with mild cognitive impairment due to Alzheimer's disease (N = 5, age 62-88 years), and controls (N = 17, age 41-82 years). Sample set II included cerebrospinal fluid samples from patients with dementia due to Alzheimer's disease (N = 24, age 52-84 years), patients with mild cognitive impairment due to Alzheimer's disease (N = 18, age 58-83 years), and controls (N = 36, age 43-80 years). RESULTS: The reproducibility of the novel method showed coefficients of variation of the measured synaptotagmin-1 peptide 215-223 (VPYSELGGK) and peptide 238-245 (HDIIGEFK) of 14 % or below. In both investigated sample sets, the CSF levels of synaptotagmin-1 were significantly increased in patients with dementia due to Alzheimer's disease (P ≤ 0.0001) and in patients with mild cognitive impairment due to Alzheimer's disease (P < 0.001). In addition, in sample set I the synaptotagmin-1 level was significantly higher in patients with mild cognitive impairment due to Alzheimer's disease compared with patients with dementia due to Alzheimer's disease (P ≤ 0.05). CONCLUSIONS: Cerebrospinal fluid synaptotagmin-1 is a promising biomarker to monitor synaptic dysfunction and degeneration in Alzheimer's disease that may be useful for clinical diagnosis, to monitor effect on synaptic integrity by novel drug candidates, and to explore pathophysiology directly in patients with Alzheimer's disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neurogranin, synaptogamin, and SNAP-25 are the strongest candidates for in vivo tracking of synaptic homeostasis.
“Neurogranin (a key regulator of the calcium-binding protein calmodulin), synaptogamin (a calcium sensor protein), and SNAP-25 (a component of the SNARE [soluble N-ethylmaleimide sensitive factor attachment protein receptor] complex) are the strongest candidates for in vivo tracking synaptic homeostasis (131–133).”
From The β-Secretase BACE1 in Alzheimer’s Disease (2021) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 1× · see citing works
“For each patient, diagnosis was made considering CSF results and according to validated clinical diagnostic criteria for dementia due to Alzheimer’s disease [28], MCI due to Alzheimer’s disease [29, 30], subjective cognitive impairment [31], and psychiatric disorder (DSM-IV).”
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · see citing works
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · see citing works
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321 · see citing works
Self-citationBlennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134 · see citing works
Self-citationAlbert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,630 · see citing works
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · see citing works
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049 · see citing works
Self-citationCerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works
Self-citationPrevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610 · see citing works
Self-citationSynaptotagmin I: A major Ca2+ sensor for transmitter release at a central synapse
Geppert, M., Goda, Y., Hammer, R. E., Li, C., Rosahl, T. W., Stevens, C. F., & Südhof, T. C. (1994) · Cell · doi:10.1016/0092-8674(94)90556-8 · Cited by 1,483 · see citing works
Molecular machines governing exocytosis of synaptic vesicles
Jahn, R., & Fasshauer, D. (2012) · Nature · doi:10.1038/nature11320 · Cited by 973 · see citing works
Tapiola, T., Alafuzoff, I., Herukka, S.-K., Parkkinen, L., Hartikainen, P., Soininen, H., & Pirttilä, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.596 · Cited by 896 · see citing works
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.1.127 · Cited by 720 · see citing works
Davies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628 · see citing works
Buerger, K., Ewers, M., Pirttila, T., Zinkowski, R., Alafuzoff, I., Teipel, S. J., DeBernardis, J., Kerkman, D., McCulloch, C., Soininen, H., et al. (2006) · Brain · doi:10.1093/brain/awl269 · Cited by 586 · see citing works
Südhof, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100052200 · Cited by 503 · see citing works
Synaptotagmins: C2-domain proteins that regulate membrane traffic.
Südhof, T., & Rizo, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80171-3 · Cited by 450 · see citing works
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Mattsson, N., Andréasson, U., Persson, S., Arai, H., Batish, S. D., Bernardini, S., Bocchio‐Chiavetto, L., Blankenstein, M. A., Carrillo, M. C., Chalbot, S., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2243 · Cited by 409 · see citing works
Self-citationSynaptic pathology in Alzheimer's disease: a review of ultrastructural studies
Scheff, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.002 · Cited by 391 · see citing works
Kvartsberg, H., Duits, F. H., Ingelsson, M., Andreasen, N., Öhrfelt, A., Andersson, K., Brinkmalm, G., Lannfelt, L., Minthon, L., Hansson, O., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.10.009 · Cited by 339 · see citing works
Self-citationBrinkmalm, A., Brinkmalm, G., Honer, W. G., Frölich, L., Hausner, L., Minthon, L., Hansson, O., Wallin, A., Zetterberg, H., Blennow, K., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-53 · Cited by 293 · see citing works
Self-citationBlennow, K., Bogdanović, N., Alafuzoff, I. I., Ekman, R., & Davidsson, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01273157 · Cited by 207 · see citing works
Self-citationFunctional properties of multiple synaptotagmins in brain.
Ullrich, B., Li, C., Zhang, J. Z., McMahon, H., Anderson, R. G. W., Geppert, M., & Südhof, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90415-4 · Cited by 199 · see citing works
Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I.
Zhang, X., Rizo, J., & Südhof, T. (1998) · Biochemistry · doi:10.1021/bi9807512 · Cited by 190 · see citing works
Neurochemical Dissection of Synaptic Pathology in Alzheimer's Disease
Davidsson, P., & Blennow, K. (1998) · International Psychogeriatrics · doi:10.1017/s1041610298005110 · Cited by 179 · see citing works
Self-citationGourmaud, S., Paquet, C., Dumurgier, J., Pace, C., Bouras, C., Gray, F., Laplanche, J., MEURS, E. F., Mouton‐Liger, F., & Hugon, J. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140062 · Cited by 95 · see citing works
Self-citationIdentification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling
Baker, K., Gordon, S. L., Grozeva, D., van Kogelenberg, M., Roberts, N. Y., Pike, M. G., Blair, E. M., Hurles, M. E., Chong, W. K., Baldeweg, T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79765 · Cited by 93 · see citing works
Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid
Davidsson, P., Jahn, R., Bergquist, J., Ekman, R., & Blennow, K. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815094 · Cited by 88 · see citing works
Self-citationBacaj, T., Wu, D., Burré, J., Malenka, R., Liu, X., & Südhof, T. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002267 · Cited by 80 · see citing works
Rufener, E., Frazier, A. A., Wieser, C. M., Hinderliter, A., & Cafiso, D. S. (2005) · Biochemistry · doi:10.1021/bi048370d · Cited by 79 · see citing works
Lynch, K. L., Gerona, R. R. L., Larsen, E. C., Marcia, R. F., Mitchell, J. C., & Martin, T. F. J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0368 · Cited by 74 · see citing works
Mouton‐Liger, F., Wallon, D., Troussière, A., Yatimi, R., Dumurgier, J., Magnin, É., Sayette, V. D. L., Duron, E., Philippi, N., Beaufils, É., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7160-3 · Cited by 67 · see citing works
Self-citationMouton‐Liger, F., Paquet, C., Dumurgier, J., Lapalus, P., Gray, F., Laplanche, J., & Hugon, J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.031 · Cited by 64 · see citing works
Self-citationMasliah, E., Honer, W. G., Mallory, M. E., Voigt, M., Kushner, P. D., Hansen, L. A., & Terry, R. D. (1994) · Acta Neuropathologica · doi:10.1007/bf00296182 · Cited by 56 · see citing works
Yoo, B. C., Cairns, N. J., Fountoulakis, M., & Lübec, G. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051261 · Cited by 54 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Biomarkers for Alzheimer's disease: current status and prospects for the future
Blennow, K., & Zetterberg, H. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12816 · Cited by 1,000 · see citing works
Self-citationThe β-Secretase BACE1 in Alzheimer’s Disease
Hampel, H., Vassar, R., De Strooper, B., Hardy, J., Willem, M., Singh, N., Zhou, J., Yan, R., Vanmechelen, E., De Vos, A., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.001 · Cited by 694 · see citing works
Current state of Alzheimer’s fluid biomarkers
Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., Fagan, A. M., Hampel, H., Mielke, M. M., Mikulskis, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1932-x · Cited by 518 · see citing works
Self-citationBlood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
Jia, L., Zhu, M., Kong, C., Pang, Y., Zhang, H., Qiu, Q., Wei, C., Tang, Y., Wang, Q., Li, Y., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12166 · Cited by 251 · see citing works
The synapse in traumatic brain injury
Jamjoom, A. A. B., Rhodes, J. K. J., Andrews, P., & Grant, S. G. N. (2020) · Brain · doi:10.1093/brain/awaa321 · Cited by 243 · see citing works
Lleó, A., Núñez-Llaves, R., Alcolea, D., Chiva, C., Balateu-Paños, D., Colom-Cadena, M., Gomez-Giro, G., Muñoz, L., Querol-Vilaseca, M., Pegueroles, J., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001290 · Cited by 219 · see citing works
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Ashton, N. J., Hye, A., Rajkumar, A. P., Leuzy, A., Snowden, S. G., Suárez‐Calvet, M., Karikari, T. K., Schöll, M., Joie, R. L., Rabinovici, G. D., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0348-0 · Cited by 186 · see citing works
Self-citationFluid Biomarkers for Synaptic Dysfunction and Loss
Camporesi, E., Nilsson, J., Brinkmalm, A., Becker, B., Ashton, N. J., Blennow, K., & Zetterberg, H. (2020) · Biomarker Insights · doi:10.1177/1177271920950319 · Cited by 165 · see citing works
Self-citationCerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
McGrowder, D. A., Miller, F. G., Vaz, K., Nwokocha, C. R., Wilson-Clarke, C. F., Anderson, M., Brown, J., Anderson-Jackson, L., Williams, L., Latore, L., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11020215 · Cited by 167 · see citing works
Muraoka, S., Jedrychowski, M. P., Yanamandra, K., Ikezu, S., Gygi, S. P., & Ikezu, T. (2020) · Cells · doi:10.3390/cells9091959 · Cited by 157 · see citing works
Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Mahaman, Y. A. R., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J.-Z., Liu, R., Feng, J., & Wang, X. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101544 · Cited by 149 · see citing works
The Past and the Future of Alzheimer’s Disease Fluid Biomarkers
Blennow, K., & Zetterberg, H. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170773 · Cited by 148 · see citing works
Self-citationSathe, G., Na, C. H., Renuse, S., Madugundu, A. K., Albert, M., Moghekar, A., & Pandey, A. (2019) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201800105 · Cited by 126 · see citing works
Cano, A., Turowski, P., Ettcheto, M., Duskey, J. T., Tosi, G., Sánchez-López, E., García, M. L., Camins, A., Souto, E. B., Ruiz, A., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00864-x · Cited by 122 · see citing works
Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders
Morozova, A. Y., Zorkina, Y., Abramova, O. V., Pavlova, O., Ka, P., Soloveva, K., Volkova, M., Alekseeva, P. A., Andryshchenko, A., Kostyuk, G. P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031217 · Cited by 126 · see citing works
Milà‐Alomà, M., Brinkmalm, A., Ashton, N. J., Kvartsberg, H., Shekari, M., Operto, G., Salvadó, G., Falcón, C., Gispert, J. D., Vilor‐Tejedor, N., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012853 · Cited by 117 · see citing works
Self-citationShi, Z., Zhang, K., Zhou, H., Jiang, L., Xie, B., Wang, R., Xia, W., Yin, Y., Gao, Z., Cui, D., et al. (2020) · Aging Cell · doi:10.1111/acel.13125 · Cited by 115 · see citing works
An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead
Simrén, J., Ashton, N. J., Blennow, K., & Zetterberg, H. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.019 · Cited by 100 · see citing works
Self-citationIzzo, N. J., Yuede, C. M., Mozzoni, K., Limegrover, C. S., Rehak, C., Yurko, R., Waybright, L., Look, G. C., Rishton, G. M., Safferstein, H., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12302 · Cited by 101 · see citing works
Self-citationCurrent advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease
Leuzy, A., Cullen, N. C., Mattsson, N., & Hansson, O. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000904 · Cited by 92 · see citing works
Self-citationEitan, E., Thornton‐Wells, T. A., Elgart, K., Erden, E., Gershun, E., Levine, A. A., Volpert, O. V., Azadeh, M., Smith, D. G., & Kapogiannis, D. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.13 · Cited by 90 · see citing works
Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
Villa, C., Lavitrano, M., Salvatore, E., & Combi, R. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030061 · Cited by 89 · see citing works
Multipronged diagnostic and therapeutic strategies for Alzheimer's disease
Ramesh, M., & Govindaraju, T. (2022) · Chemical Science · doi:10.1039/d2sc03932j · Cited by 87 · see citing works
Current Biomarkers for Alzheimer’s Disease: From CSF to Blood
Zou, K., Abdullah, M., & Michikawa, M. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030085 · Cited by 83 · see citing works
Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease
Tible, M., Sandelius, Å., Höglund, K., Brinkmalm, A., Cognat, E., Dumurgier, J., Zetterberg, H., Hugon, J., Paquet, C., & Blennow, K. (2020) · Neurology · doi:10.1212/wnl.0000000000010131 · Cited by 83 · see citing works
Self-citationCerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
Nilsson, J., Gobom, J., Sjödin, S., Brinkmalm, G., Ashton, N. J., Svensson, J., Johansson, P., Portelius, E., Zetterberg, H., Blennow, K., et al. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12179 · Cited by 82 · see citing works
Self-citationNilsson, J., Binette, A. P., Palmqvist, S., Brum, W. S., Janelidze, S., Ashton, N. J., Spotorno, N., Stomrud, E., Gobom, J., Zetterberg, H., et al. (2024) · Brain · doi:10.1093/brain/awae032 · Cited by 82 · see citing works
Self-citationAn overview of the genes and biomarkers in Alzheimer’s disease
Krishnamurthy, H. K., Jayaraman, V., Krishna, K., Wang, T., Bei, K., Changalath, C., & Rajasekaran, J. J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102599 · Cited by 85 · see citing works
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
Milà‐Alomà, M., Suárez‐Calvet, M., & Molinuevo, J. L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419888819 · Cited by 78 · see citing works
Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
Swarup, V., Chang, T. S., Duong, D. M., Dammer, E. B., Dai, J., Lah, J. J., Johnson, E. C. B., Seyfried, N. T., Levey, A. I., & Geschwind, D. H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107807 · Cited by 78 · see citing works
Identification of conserved proteomic networks in neurodegenerative dementia
Swarup, V., Chang, T. S., Duong, D. M., Dammer, E. B., Lah, J. J., Johnson, E. E. C. B., Seyfried, N. T., Levey, A. I., & Geschwind, D. H. (2019) · doi:10.1101/825802 · Cited by 78 · see citing works
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
Heurling, K., Ashton, N. J., Leuzy, A., Zimmer, E. R., Blennow, K., Zetterberg, H., Eriksson, J., Lubberink, M., & Schöll, M. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.02.001 · Cited by 77 · see citing works
Self-citationKorecka, M., & Shaw, L. M. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15465 · Cited by 79 · see citing works
Presynaptic failure in Alzheimer's disease
Barthet, G., & Mulle, C. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101801 · Cited by 74 · see citing works
Dridi, H., Liu, Y., Reiken, S. R., Liu, X., Argyrousi, E. K., Yuan, Q., Miotto, M., Sittenfeld, L. R., Meddar, A., Soni, R. K., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01377-6 · Cited by 69 · see citing works
Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease
Picard, C., Nilsson, N., Labonté, A., Auld, D., Rosa‐Neto, P., Initiative, T. A. D. N., Ashton, N. J., Zetterberg, H., Blennow, K., Breitner, J. C. B., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12442 · Cited by 66 · see citing works
Self-citationShanks, H. R. C., Chen, K., Reiman, E. M., Blennow, K., Cummings, J. L., Massa, S. M., Longo, F. M., Börjesson‐Hanson, A., Windisch, M., & Schmitz, T. W. (2024) · Nature Medicine · doi:10.1038/s41591-024-02977-w · Cited by 61 · see citing works
Self-citationCompta, Y., & Révész, T. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202323 · Cited by 61 · see citing works
Clarke, M. T. M., Brinkmalm, A., Foiani, M. S., Woollacott, I. O. C., Heller, C., Heslegrave, A., Keshavan, A., Fox, N. C., Schott, J. M., Warren, J. D., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0564-2 · Cited by 58 · see citing works
Self-citationFluid biomarkers in Alzheimer's disease
Simrén, J., Elmgren, A., Blennow, K., & Zetterberg, H. (2023) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2022.09.006 · Cited by 58 · see citing works
Self-citationNiu, X., Jiang, X., Xu, G.-D., Zheng, G.-M., Tang, Z., Yin, N., Li, X.-Q., Yang, Y.-Y., & Lv, P.-Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27332 · Cited by 56 · see citing works
Nilsson, J., Constantinescu, J., Nellgård, B., Jakobsson, P., Brum, W. S., Gobom, J., Forsgren, L., Dalla, K., Constantinescu, R., Zetterberg, H., et al. (2022) · Movement Disorders · doi:10.1002/mds.29287 · Cited by 56 · see citing works
Self-citationClinical significance of fluid biomarkers in Alzheimer’s Disease
Lewczuk, P., Łukaszewicz‐Zając, M., Mroczko, P., & Kornhuber, J. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00107-0 · Cited by 53 · see citing works
Obrocki, P., Khatun, A., Ness, D., Senkevich, K. A., Hanrieder, J., Capraro, F., Mattsson, N., Andréasson, U., Portelius, E., Ashton, N. J., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00586-6 · Cited by 51 · see citing works
Self-citationHampel, H. J., Vergallo, A., Caraci, F., Cuello, A. C., Lemercier, P., Vellas, B. J., Giudici, K. V., Baldacci, F., Hänisch, B., Haberkamp, M., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108081 · Cited by 50 · see citing works
Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
Rani, S., Dhar, S. B., Khajuria, A., Gupta, D., Jaiswal, P. K., Singla, N., Kaur, M., Singh, G., & Barnwal, R. P. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01330-y · Cited by 48 · see citing works
Blennow, K., & Zetterberg, H. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.006 · Cited by 46 · see citing works
Self-citationUrinary metabolic phenotyping for Alzheimer’s disease
Kurbatova, N., Garg, M., Whiley, L., Chekmeneva, E., Jiménez, B., Gómez-Romero, M., Pearce, J., Kimhofer, T., D’Hondt, E., Soininen, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78031-9 · Cited by 44 · see citing works
Öhrfelt, A., Benedet, A. L., Ashton, N. J., Kvartsberg, H., Vandijck, M. L. J., Weiner, M. W., Trojanowski, J. Q., Shaw, L. M. J., Zetterberg, H., Blennow, K., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201417 · Cited by 44 · see citing works
Self-citationBridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
Bjorkli, C., Sandvig, A., & Sandvig, I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00272 · Cited by 40 · see citing works
Qiang, Q., Skudder‐Hill, L., Toyota, T., Wei, W., & Adachi, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-20324-2 · Cited by 40 · see citing works
Halbgebauer, S., Steinacker, P., Riedel, D., Oeckl, P., Anderl‐Straub, S., Lombardi, J., Arnim, C. A. F. V., Nagl, M., Giese, A., Ludolph, A. C., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01122-4 · Cited by 40 · see citing works
Lista, S., Santos‐Lozano, A., Emanuele, E., Mercuri, N. B., Gabelle, A., López‐Ortiz, S., Martín-Hernández, J., Maisto, N., Imbimbo, C., Caraci, F., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02376-6 · Cited by 42 · see citing works
Self-citationAdvantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
Omar, S. H., & Preddy, J. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030063 · Cited by 40 · see citing works
Navigating the intersection: Diabetes and Alzheimer's intertwined relationship
Kale, M. B., Bhondge, H. M., Wankhede, N. L., Shende, P. V., Thanekar, R., Aglawe, M. M., Rahangdale, S. R., Taksande, B. G., Pandit, S. B., Upaganlawar, A. B., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102415 · Cited by 38 · see citing works
Organ-specific proteomic aging clocks predict disease and longevity across diverse populations
Wang, Y., Xiao, S., Liu, B., Jiang, R., Liu, Y., Hang, Y., Chen, L., Chen, R., Vitiello, M. V., Bennett, D., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01016-8 · Cited by 44 · see citing works
Karmakar, S., Sharma, L. G., Roy, A., Patel, A., & Pandey, L. M. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.12.001 · Cited by 37 · see citing works
Biomarkers: Our Path Towards a Cure for Alzheimer Disease
Tarawneh, R. M. (2020) · Biomarker Insights · doi:10.1177/1177271920976367 · Cited by 37 · see citing works
Öhrfelt, A., Brinkmalm, A., Dumurgier, J., Zetterberg, H., Bouaziz-Amar, É., Hugon, J., Paquet, C., & Blennow, K. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.11.038 · Cited by 35 · see citing works
Self-citationβ-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
Mohaupt, P., Pons, M., Vialaret, J., Delaby, C., Hirtz, C., & Lehmann, S. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01125-1 · Cited by 34 · see citing works
Lan, G., Li, A., Liu, Z., Ma, S., Guo, T., & Initiative, A. D. N. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12890 · Cited by 31 · see citing works
Yang, W., Xu, Q., Yuan, Q., Xian, Y., & Lin, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109504 · Cited by 32 · see citing works
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases
Mazzucchi, S., Palermo, G., Campese, N., Galgani, A., Vecchia, A. D., Vergallo, A., Siciliano, G., Ceravolo, R., Hampel, H. J., & Baldacci, F. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1831388 · Cited by 32 · see citing works
Tobeh, N. S., & Bruce, K. D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1259012 · Cited by 31 · see citing works
Gao, X., Sun, H., Wei, Y.-D., Niu, J., Hao, S., Sun, H., Tang, G., Qi, C., & Ge, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155805 · Cited by 30 · see citing works
Chaudhry, A., Houlden, H., & Rizig, M. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116886 · Cited by 30 · see citing works
Louros, N., Ramakers, M., Michiels, E., Konstantoulea, K., Morelli, C., Garcia, T., Moonen, N., D’Haeyer, S., Goossens, V., Thal, D. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28955-9 · Cited by 28 · see citing works
Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons
Nazir, F. H., Becker, B., Brinkmalm, A., Höglund, K., Sandelius, Å., Bergström, P., Şatır, T. M., Öhrfelt, A., Blennow, K., Agholme, L., et al. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.10.014 · Cited by 26 · see citing works
Self-citationProteomic studies of cerebrospinal fluid biomarkers of Alzheimer’s disease: an update
Portelius, E., Brinkmalm, G., Pannee, J., Zetterberg, H., Blennow, K., Dahlén, R., Brinkmalm, A., & Gobom, J. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1384697 · Cited by 26 · see citing works
Self-citationHas the time arrived for cerebrospinal fluid biomarkers in psychiatric disorders?
Lleó, A., Parnetti, L., Belbin, O., & Wiltfang, J. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.01.019 · Cited by 26 · see citing works
Function of Drosophila Synaptotagmins in membrane trafficking at synapses
Quiñones-Frías, M. C., & Littleton, J. T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03788-9 · Cited by 23 · see citing works
Molecular Profiles of Amyloid-β Proteoforms in Typical and Rapidly Progressive Alzheimer’s Disease
Noor, A., Zafar, S., Shafiq, M., Younas, N., Siegert, A., Mann, F. A., Kruss, S., Schmitz, M., Dihazi, H., Ferrer, I., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02566-9 · Cited by 27 · see citing works
Quesnel, M. J., Labonté, A., Picard, C., Zetterberg, H., Blennow, K., Brinkmalm, A., Villeneuve, S., Poirier, J., Initiative, A. D. N., Weiner, M. W., et al. (2023) · Brain · doi:10.1093/brain/awad398 · Cited by 23 · see citing works
Self-citationZhang, Y., Guo, Y. X., He, Y., You, J., Zhang, Y., Wang, L., Chen, S., He, X., Yang, L., Huang, Y., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02840-x · Cited by 22 · see citing works
Vortioxetine administration attenuates cognitive and synaptic deficits in 5×FAD mice
Jiang, L., Huang, G.-D., Feng, S., Wang, H., Zhang, C., & Yu, X. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05452-9 · Cited by 21 · see citing works
Giampietri, L., Belli, E., Beatino, M. F., Giannoni, S., Palermo, G., Campese, N., Tognoni, G., Siciliano, G., Ceravolo, R., Luca, C. D., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12040796 · Cited by 22 · see citing works
Zarbock, K. R., Han, J. H., Singh, A. P., Thomas, S. P., Bendlin, B. B., Denu, J. M., Yu, J. J., Rey, F. E., & Ulland, T. K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220413 · Cited by 23 · see citing works
Amyloid pathology and synaptic loss in pathological aging
Gkanatsiou, E., Nilsson, J., Toomey, C. E., Vrillon, A., Kvartsberg, H., Portelius, E., Zetterberg, H., Blennow, K., Brinkmalm, A., Lashley, T., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15487 · Cited by 21 · see citing works
Self-citationPromising protein biomarkers in the early diagnosis of Alzheimer’s disease
Sharma, L. K., Sharma, A., Kumar, D., Asthana, M. K., Lalhlenmawia, H., Kumar, A., Bhattacharyya, S., & Kumar, D. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00847-9 · Cited by 22 · see citing works
Brinkmalm, A., Portelius, E., Brinkmalm, G., Pannee, J., Dahlén, R., Gobom, J., Blennow, K., & Zetterberg, H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14594 · Cited by 21 · see citing works
Self-citationOsteopontin: A novel marker of pre‐symptomatic sporadic Alzheimer's disease
Quesnel, M. J., Labonté, A., Picard, C., Bowie, D. C., Zetterberg, H., Blennow, K., Brinkmalm, A., Villeneuve, S., Poirier, J., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14065 · Cited by 20 · see citing works
Self-citationFluid biomarkers for neurodegenerative diseases: a comprehensive update
Valletta, M., Briel, N., Yuksekel, I., Barboure, M. C., Coward, A. R., Houwer, J. F. H. D., Fawad, A., González-Mayoral, A., Iaccarino, G., Martínez‐Dubarbie, F., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01919-z · Cited by 21 · see citing works
Self-citationÖhrfelt, A., Dumurgier, J., Zetterberg, H., Vrillon, A., Ashton, N. J., Kvartsberg, H., Bouaziz-Amar, É., Hugon, J., Paquet, C., & Blennow, K. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00748-6 · Cited by 19 · see citing works
Self-citationRole of calcium-sensor proteins in cell membrane repair
Li, Z., & Shaw, G. S. (2023) · Bioscience Reports · doi:10.1042/bsr20220765 · Cited by 20 · see citing works
Zhang, H., Lyu, D., Jia, J., & Initiative, A. D. N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215456 · Cited by 18 · see citing works
SYT1-Associated Neurodevelopmental Disorder: A Narrative Review
Riggs, E., Shakkour, Z., Anderson, C. L., & Carney, P. R. (2022) · Children · doi:10.3390/children9101439 · Cited by 18 · see citing works
Goossens, J., González, A. C., Dewit, N., Lidón, L., Fortea, J., Alcolea, D. A., Lleó, A., Belbin, O., & Vanmechelen, E. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01336-0 · Cited by 18 · see citing works
Alzheimer's Disease Biomarker Analysis Using Targeted Mass Spectrometry
Gobom, J., Brinkmalm, A., Brinkmalm, G., Blennow, K., & Zetterberg, H. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100721 · Cited by 18 · see citing works
Self-citationMohammadi, H., Ariaei, A., Ghobadi, Z., Gorgich, E. A. C., & Rustamzadeh, A. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.02.007 · Cited by 18 · see citing works
Weerakkody, J. S., Tseng, T., Topper, M., Thoduvayil, S., Radhakrishnan, A., Pincet, F., Kyriakides, T. R., Gunasekara, R. W., & Ramakrishnan, S. K. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202400390 · Cited by 18 · see citing works
Bartl, M., Nilsson, J., Dakna, M., Weber, S., Schade, S., Xylaki, M., Gomes, B. F., Ernst, M. S., Muntean, M., Sixel‐Döring, F., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00714-1 · Cited by 18 · see citing works
Self-citationProteomics Landscape of Alzheimer’s Disease
Jain, A., & Sathe, G. J. (2021) · Proteomes · doi:10.3390/proteomes9010013 · Cited by 17 · see citing works
Synaptic Proteins as Fluid Biomarkers in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Roveta, F., Cermelli, A., Boschi, S., Ferrandes, F., Grassini, A., Marcinnò, A., Spina, M., Rubino, E., Borsello, T., Vercelli, A., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220515 · Cited by 17 · see citing works
Evolutionary and genomic perspectives of brain aging and neurodegenerative diseases
Dames, B. A. R., Kilili, H., Charvet, C. J., Díaz-Barba, K., Proulx, M. J., de Sousa, A. A., & Urrutia, A. O. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2022.10.004 · Cited by 18 · see citing works
Early Detection and Treatment of Patients with Alzheimer’s Disease: Future Perspectives
Guest, F. L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_15 · Cited by 17 · see citing works
Dauar, M. T., Labonté, A., Picard, C., Miron, J., Rosa‐Neto, P., Zetterberg, H., Blennow, K., Villeneuve, S., & Poirier, J. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12868 · Cited by 16 · see citing works
Self-citationAbdelmohsen, K., Herman, A. B., Carr, A. E., Henry-Smith, C., Rossi, M. S., Meng, Q., Yang, J., Tsitsipatis, D., Bangura, A., Munk, R. B., et al. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.106 · Cited by 16 · see citing works
Ke, Y. D., Chan, G., Stefanoska, K., Au, C. G., Bi, M., Müller, J., Przybyla, M., Feiten, A., Prikas, E., Halliday, G. M., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005263 · Cited by 16 · see citing works
PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer’s disease
Poirier, A., Picard, C., Labonté, A., Aubry, I., Auld, D. S., Zetterberg, H., Blennow, K., Poirier, J., Breitner, J. C. S., Poirier, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65104-2 · Cited by 13 · see citing works
Self-citation
- Authors
- Öhrfelt, A., Brinkmalm, A., Dumurgier, J., Brinkmalm, G., Hansson, O., Zetterberg, H., Bouaziz-Amar, E., Hugon, J., Paquet, C., & Blennow, K.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Inserm (FR)
- Lund University (SE)
- Corresponding author
- Öhrfelt, Annika
- ORCID
- Venue
- Alzheimer's Research & Therapy
- Published
- 2016-10-03
- Volume
- 8
- Issue
- 1
- Pages
- 41-41
- ISSN
- 1758-9193 (ISSN-L)
- PMC
- PMC5048479
- OpenAlex
- W2529693680
- Cited by
- 184
- References
- 40
- Citations by year
- 2026: 6 · 2025: 17 · 2024: 35 · 2023: 18 · 2022: 31 · 2021: 22 · 2020: 26 · 2019: 14 · 2018: 13 · 2017: 2
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Alzheimer s Research & Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Swedish Brain Power
- Swedish research council
- Swedish Alzheimer foundation
- European research council
- ALF
- The Knut and Wallenberg foundation
- Demensfonden
- Eivind och Elsa K:son Sylvans stiftelse
- the Wolfson foundation
- Märtha och Gustaf Ågrens stiftelse
- Gun och Bertil Stohnes Stiftelse
- Stiftelsen gamla tjänarinnor
- Magnus Bergvalls Stiftelse
- Svenska Läkaresällskapet
- Åhlén-stiftelsen
- BMBF BIOMARK-APD
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- synaptotagmin-1, Alzheimer's disease, cerebrospinal fluid biomarkers, synaptic dysfunction, synaptic degeneration, mild cognitive impairment, dementia, cognitive decline, drug monitoring, neurodegeneration biomarkers, tau protein, neuroinflammation, neurofibrillary tangles, neurodegeneration
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Cognition Disorders, Dementia, Female, Humans, Male, Middle Aged, Peptide Fragments, Peptides, Psychiatric Status Rating Scales, ROC Curve, Mass Spectrometry, Amyloid beta-Peptides, tau Proteins, Immunoprecipitation, Synaptotagmin I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
